Treatment with rivaroxaban and ASA, after successful endovascular recanalization, in a subject with multi complicated peripheral arterial disease. Case report

Preserving the clinical result of revascularization in diabetic patients, usually affected by a complex and often progressive form of arteriopathy, is a mandatory challenge to reduce major amputations rate and the related mortality rate as well. Low doses of the new NOAC anticoagulant drugs, more manageable than traditional coumarin drugs, if associated with ASA and / or clopidogrel, have shown a significant efficacy in thrombosis prevention, in subjects who underwent endovascular or surgical revascularization. Contraindications end cautions are necessary in subjects with ESRD, dialysis, mechanical prosthetic heart valves and old in age. KEY WORDS peripheral arterial disease; diabetes; thrombosis; anticoagulants.